Posted November 5, 2008
RTP startup Entegrion launches sales of blood-loss dressing
Post a comment
Print this storyE-mail story
Share
Research Triangle Park, N.C. —
RTP startup Entegrion, which is developing blood coagulation and related technologies, is launching commercial sales of its proprietary bandages that are designed to promote blood clotting.
The company, which utilizes technology developed at the University of North Carolina at Chapel Hill and East Carolina University, recently received Food and Drug Administration approval for one of its Stasilon, a bandage that promotes blood clotting.
The bandages will be sold by LC Industries, which is based in Durham.
Entegrion developed the technology in cooperation with the U.S. Office of Naval research.
The bandages come in 4-inch and 2-inch square sizes.
Featured
Hot Off The Wire
- Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
- Will Cisco report progress in its turnaround efforts?
- Cisco server fire threat; Lenovo Android upgrade; cloud startup vs. Cisco; Epic's Blesinski to host awards; Google 'Solve for X'
E-mail Preferences
